Phibro Animal Health 

$31.53
26
+$0.27+0.86% Friday 20:00

Statistics

Day High
32.19
Day Low
31.21
52W High
59.58
52W Low
23.88
Volume
183,000
Avg. Volume
-
Mkt Cap
650.27M
P/E Ratio
13.63
Dividend Yield
1.52%
Dividend
0.48

Upcoming

Dividends

1.52%Dividend Yield
Jun 26
$0.12
Mar 26
$0.12
Dec 25
$0.12
Sep 25
$0.12
Jun 25
$0.12
10Y Growth
1.84%
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

2SepExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.43
0.57
0.72
0.87
Expected EPS
0.712975
Actual EPS
N/A

Financials

7.57%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
2.59BRevenue
196.19MNet Income

Analyst Ratings

44.00Average Price Target
The highest estimate is 44.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PAHC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.
Show more...
CEO
Mr. Jack Clifford Bendheim
Employees
1940
Country
United States
ISIN
US71742Q1067

Listings

0 Comments

Share your thoughts

FAQ

What is Phibro Animal Health stock price today?
The current price of PAHC is $31.53 USD — it has increased by +0.86% in the past 24 hours. Watch Phibro Animal Health stock price performance more closely on the chart.
What is Phibro Animal Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Phibro Animal Health stocks are traded under the ticker PAHC.
Is Phibro Animal Health stock price growing?
PAHC stock has fallen by -0.72% compared to the previous week, the month change is a -8.26% fall, over the last year Phibro Animal Health has showed a +31.76% increase.
What is Phibro Animal Health market cap?
Today Phibro Animal Health has the market capitalization of 650.27M
When is the next Phibro Animal Health earnings date?
Phibro Animal Health is going to release the next earnings report on September 02, 2026.
What were Phibro Animal Health earnings last quarter?
PAHC earnings for the last quarter are 0.76 USD per share, whereas the estimation was 0.71 USD resulting in a +6.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Phibro Animal Health revenue for the last year?
Phibro Animal Health revenue for the last year amounts to 2.59B USD.
What is Phibro Animal Health net income for the last year?
PAHC net income for the last year is 196.19M USD.
Does Phibro Animal Health pay dividends?
Yes, PAHC dividends are paid quarterly. The last dividend per share was 0.12 USD. As of today, Dividend Yield (FWD)% is 1.52%.
How many employees does Phibro Animal Health have?
As of June 15, 2026, the company has 1,940 employees.
In which sector is Phibro Animal Health located?
Phibro Animal Health operates in the Health & Wellness sector.
When did Phibro Animal Health complete a stock split?
Phibro Animal Health has not had any recent stock splits.
Where is Phibro Animal Health headquartered?
Phibro Animal Health is headquartered in Teaneck, United States.